BioLargo, Inc. (BLGO) stock
BLGOOTCChemicals & Allied ProductsFiscal year ends December 31
$0.07+0.00 (+0.90%)
Close on Oct 19, 2026Market cap $23.27MP/E –Yield –
BioLargo shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
BioLargo's shares outstanding was 321M at Jun 30, 2026. For fiscal 2025 it was 307M, up 3.0% from the year before. Over ten years it grew 13.8% a year on average. The highest annual figure on record is 307M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 307M | +3.0% |
| FY2024 | Dec 31, 2024 | 298M | +4.3% |
| FY2023 | Dec 31, 2023 | 286M | +6.6% |
| FY2022 | Dec 31, 2022 | 268M | +8.5% |
| FY2021 | Dec 31, 2021 | 247M | +26.1% |
| FY2020 | Dec 31, 2020 | 196M | +28.9% |
| FY2019 | Dec 31, 2019 | 152M | +24.7% |
| FY2018 | Dec 31, 2018 | 122M | +23.3% |
| FY2017 | Dec 31, 2017 | 99M | +12.5% |
| FY2016 | Dec 31, 2016 | 88M | +4.5% |
| FY2015 | Dec 31, 2015 | 84M | +5.1% |
| FY2014 | Dec 31, 2014 | 80M | +9.7% |
| FY2013 | Dec 31, 2013 | 73M | +14.4% |
| FY2012 | Dec 31, 2012 | 64M | +14.4% |
| FY2011 | Dec 31, 2011 | 56M | +21.6% |
| FY2010 | Dec 31, 2010 | 46M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 321M | +5.9% |
| Q1 FY2026 | Mar 31, 2026 | 319M | +5.8% |
| Q4 FY2025 | Dec 31, 2025 | 314M | +4.3% |
| Q3 FY2025 | Sep 30, 2025 | 309M | +2.8% |
| Q2 FY2025 | Jun 30, 2025 | 303M | +2.3% |
| Q1 FY2025 | Mar 31, 2025 | 301M | +2.4% |
| Q4 FY2024 | Dec 31, 2024 | 301M | +3.8% |
| Q3 FY2024 | Sep 30, 2024 | 300M | +4.4% |
| Q2 FY2024 | Jun 30, 2024 | 296M | +4.0% |
| Q1 FY2024 | Mar 31, 2024 | 294M | +4.8% |
| Q4 FY2023 | Dec 31, 2023 | 290M | +5.2% |
| Q3 FY2023 | Sep 30, 2023 | 288M | +6.4% |
| Q2 FY2023 | Jun 30, 2023 | 285M | +7.2% |
| Q1 FY2023 | Mar 31, 2023 | 281M | +7.6% |
| Q4 FY2022 | Dec 31, 2022 | 276M | +6.8% |
| Q3 FY2022 | Sep 30, 2022 | 271M | +7.0% |
| Q2 FY2022 | Jun 30, 2022 | 266M | +9.1% |
| Q1 FY2022 | Mar 31, 2022 | 261M | +11.6% |
| Q4 FY2021 | Dec 31, 2021 | 258M | +9.8% |
| Q3 FY2021 | Sep 30, 2021 | 253M | +20.3% |
| Q2 FY2021 | Jun 30, 2021 | 244M | +34.2% |
| Q1 FY2021 | Mar 31, 2021 | 234M | +38.4% |
| Q4 FY2020 | Dec 31, 2020 | 235M | +43.7% |
| Q3 FY2020 | Sep 30, 2020 | 210M | +34.4% |
| Q2 FY2020 | Jun 30, 2020 | 182M | +24.6% |
| Q1 FY2020 | Mar 31, 2020 | 169M | +18.7% |
| Q4 FY2019 | Dec 31, 2019 | 164M | +22.3% |
| Q3 FY2019 | Sep 30, 2019 | 156M | +19.9% |
| Q2 FY2019 | Jun 30, 2019 | 146M | +22.7% |
| Q1 FY2019 | Mar 31, 2019 | 142M | +35.9% |
| Q4 FY2018 | Dec 31, 2018 | 134M | +30.3% |
| Q3 FY2018 | Sep 30, 2018 | 130M | +29.5% |
| Q2 FY2018 | Jun 30, 2018 | 119M | +21.5% |
| Q1 FY2018 | Mar 31, 2018 | 105M | +10.9% |
| Q4 FY2017 | Dec 31, 2017 | 103M | +12.5% |
| Q3 FY2017 | Sep 30, 2017 | 101M | +14.3% |
| Q2 FY2017 | Jun 30, 2017 | 98M | – |
| Q1 FY2017 | Mar 31, 2017 | 94M | – |
| Q4 FY2016 | Dec 31, 2016 | 91M | – |
| Q3 FY2016 | Sep 30, 2016 | 88M | – |
See a number that looks wrong?